Published in Virology on April 30, 1985
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
Medically important arboviruses of the United States and Canada. Clin Microbiol Rev (1994) 2.98
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43
Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay. J Clin Microbiol (1997) 1.20
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology (2006) 0.97
Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies. Clin Vaccine Immunol (2010) 0.92
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human. J Clin Microbiol (1990) 0.91
Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system. Protein Expr Purif (2011) 0.91
Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses. J Virol (2013) 0.85
Removal of species constraints in antibody detection. Clin Vaccine Immunol (2009) 0.84
The DNA sequence of human chromosome 22. Nature (1999) 30.88
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 4.61
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci (2001) 2.13
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology (1990) 1.91
West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol (2000) 1.85
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology (1982) 1.80
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J Immunol (1992) 1.71
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg (1990) 1.66
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology (1985) 1.62
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol (1982) 1.60
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
Isolation of a new flavivirus related to cell fusing agent virus (CFAV) from field-collected flood-water Aedes mosquitoes sampled from a dambo in central Kenya. Arch Virol (2003) 1.52
A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol (2000) 1.46
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Monoclonal antibodies against the flavivirus West Nile. J Gen Virol (1982) 1.33
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J Clin Microbiol (1987) 1.29
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology (1980) 1.28
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies. J Gen Virol (1982) 1.24
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
Relationships of bunyamwera group viruses by neutralization. Am J Trop Med Hyg (1979) 1.17
In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology (1988) 1.16
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol (1991) 1.10
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus. J Gen Virol (1982) 1.09
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes. J Clin Microbiol (1988) 1.08
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology (1991) 1.05
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus. Am J Trop Med Hyg (1988) 1.04
Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology (1995) 1.02
Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years. Emerg Infect Dis (1997) 1.02
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol (1988) 1.01
Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia. Am J Trop Med Hyg (1988) 1.00
Flavivirus DNA vaccines: current status and potential. Ann N Y Acad Sci (2001) 1.00
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol (1993) 1.00
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology (1994) 0.97
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology (1990) 0.97
West Nile virus. JAMA (2001) 0.94
Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J Gen Virol (1988) 0.93
Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex. Am J Trop Med Hyg (1998) 0.92
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human. J Clin Microbiol (1990) 0.91
Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses. J Clin Microbiol (1991) 0.90
T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J Virol (1991) 0.88
Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus. J Gen Virol (1990) 0.86
Specificity of the murine T helper cell immune response to various alphaviruses. J Gen Virol (1989) 0.85
Factors associated with prognosis for survival and athletic use in foals with septic arthritis: 93 cases (1987-1994). J Am Vet Med Assoc (1999) 0.82
Detection of eastern equine encephalitis virus in infected mosquitoes using a monoclonal antibody-based antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg (2001) 0.81
Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies. J Med Virol (1990) 0.81
Characteristics of a persistent rubella infection in a human cell line. J Gen Virol (1981) 0.80
Effects of 17beta-estradiol on the replication of rubella virus in an estrogen-responsive, continuous cell line. J Virol (1979) 0.80
Differentiation of parapoxviruses by application of orf virus-specific monoclonal antibodies against cell surface proteins. Vet Immunol Immunopathol (1991) 0.78
Antibodies to arboviruses in an Alaskan population at occupational risk of infection. Can J Microbiol (1988) 0.76
Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice. J Neurovirol (2009) 0.76
A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes. J Virol (1992) 0.75
Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus. Vaccine (1994) 0.75
Those closest to human suffering. Int J Trauma Nurs (1998) 0.75
Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus. Hybridoma (1999) 0.75
Laboratory testing for West Nile virus: panel discussion. Ann N Y Acad Sci (2001) 0.75
Laboratory detection of leucocyte esterase and nitrite as an alternative to urine microscopy. Eur J Clin Microbiol Infect Dis (1996) 0.75